Tuberculosis, Pulmonary: all 340 studies
Page 3 of 4. Open to participants first (69), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Intravenous Treatment of TuberculosisTerminatedNCT04150367
- POC Strategies to Improve TB Care in Advanced HIV DiseaseCompletedNCT04122404Not applicable
- Prevalence and Burden of Bronchiectasis in Tuberculous PatientsCompletedNCT04085133
- PRACTECAL-PKPD Sub StudyStatus unknownNCT04081077Phase 2/3
- Microbiome in Pulmonary Tuberculosis, Non-tuberculous Mycobacterial Pulmonary Diseases, Lung Cancer and HemoptysisCompletedNCT04079400
- Evaluation of CRISPR-based Test for the Rapid Identification of TB in Pulmonary Tuberculosis SuspectsStatus unknownNCT04074369
- PCR Techniques of Dried Sputum Using a SpotcardStatus unknownNCT04055584
- A Study of Pattern of Presentation of Pulmonary Tuberculosis Patients Undergoing Treatment at Assiut University HospitalStatus unknownNCT04055441
- Study on the Management Model of "Home Treatment" for Tuberculosis PatientsStatus unknownNCT03967353Not applicable
- PanACEA Sutezolid Dose-finding and Combination EvaluationCompletedNCT03959566Phase 2
- Azacytidine During Anti-tuberculosis TherapyWithdrawnNCT03941496Phase 1/2
- Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)CompletedNCT03896685Phase 3
- Novel Triple-dose Tuberculosis Retreatment Regimens: How to Overcome Resistance Without Creating MoreWithdrawnNCT03862248Phase 3
- Clinical Analysis of the Patients With Cavitary Pulmonary TB and Endobronchial TB in the PPM-UUH CohortCompletedNCT03822156
- Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PBTZ169 in Multiple DosingCompletedNCT03776500Phase 1
- Bronchial Washings in Sputum Scarce Cases of Pulmonary TuberculosisWithdrawnNCT03732014
- Xpert MTB/XDR Clinical Evaluation TrialCompletedNCT03728725
- Clinical Evaluation of the Truenat Point-of-care Tuberculosis Diagnostic TestCompletedNCT03712709
- Adjunctive NAC in Adult Patients With Pulmonary TuberculosisCompletedNCT03702738Phase 2
- A Single Ascending Dose Study of BTZ043CompletedNCT03590600Phase 1
- Pilot Clinical Trial of PRS TB Regimen I - Phase IICompletedNCT03561753Phase 4
- VDOT and Mobile Payments in CambodiaWithdrawnNCT03547479Not applicable
- A Pragmatic Randomised Study to Optimise Screening, Prevention and Care for Tuberculosis in MalawiStatus unknownNCT03519425Not applicable
- Rifampicin vs Rifabutin in HIV/AIDS Patients Combined With TuberculosisStatus unknownNCT03478033Not applicable
- Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive TuberculosisCompletedNCT03474198Phase 2/3
- Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Ex-vivo Antitubercular Activity of PBTZ169 FormulationCompletedNCT03423030Phase 1
- Personalization of AntiTB Treatment: Evaluation of Pharmacological Determinants of Treatment ResponseStatus unknownNCT03416309
- Evaluation of Host Biomarker-based Point-of-care Tests for Targeted Screening for Active TBCompletedNCT03350048
- Treating Tuberculosis Wasting With a High-protein SupplementTerminatedNCT03302949Not applicable
- RIPE vs RIPE Plus N-acetylcysteine in Patients With HIV/TB Co-infectionStatus unknownNCT03281226Phase 2
- Joint Management of DM2 and Pulmonary TB in Orizaba, VeracruzWithdrawnNCT03277742Not applicable
- Nanodisk-MS Assay for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis in Hospitalized PatientsCompletedNCT03271567
- TB Sequel: Pathogenesis and Risk Factors of Long-term Sequelae of Pulmonary TBStatus unknownNCT03251196
- Early Diagnosis of Active Tuberculosis Using Ultra Low-dose Chest CTStatus unknownNCT03220464Not applicable
- A Phase 1 Study to Evaluate Safety, Tolerability, PK, and PK Interactions of TBA-7371CompletedNCT03199339Phase 1
- Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SutezolidCompletedNCT03199313Phase 1
- Role of Genexpert in Extra Pulmonary TuberculosisStatus unknownNCT03173261Not applicable
- Azithromycin as Host-directed Therapy for Pulmonary TuberculosisCompletedNCT03160638Phase 2
- Safety and Immunogenicity Study of GX-70 in TB PatientWithdrawnNCT03159975Phase 1
- Accuracy and Feasibility of Xpert UltraCompletedNCT03072576
- Performance Evaluation of TB Breath- and Cough-testing PlatformsStatus unknownNCT03025516
- Line Probe Assay Evaluation StudyCompletedNCT02984579
- Evaluation of 11C-acetate PET Imaging as a Novel Approach to Detecting Pathology in Pulmonary TBStatus unknownNCT02972697Phase 1
- Evaluation of PET/MRI Using a Somatostatin Analog Tracer as a Novel Approach to Detecting Pathology in High Risk TB-exposed ContactsStatus unknownNCT02967666Phase 1
- Comparison Between Two Strategies for the Diagnosis of TBCompletedNCT02961569Not applicable
- Prospective Assessment of TBDx FeasibilityCompletedNCT02912832Not applicable
- Shortened Regimens for Drug-susceptible Pulmonary TuberculosisStatus unknownNCT02901288Phase 4
- Evaluation of Somatostatin Receptor Imaging Using PET/MRI as a Novel Approach to Detecting Pathology in Pulmonary TBStatus unknownNCT02845570Phase 1
- A Phase II Clinical Study of LCB01-0371 to Evaluate the EBA, Safety and PKCompletedNCT02836483Phase 2
- Probe Melting Technology for Rapid Detection of Drug Resistant TuberculosisStatus unknownNCT02776150
- Doxycycline in Human Pulmonary TuberculosisCompletedNCT02774993Phase 2
- Diagnostic Trial to Validate the Use of the E-Nose in Pulmonary TBStatus unknownNCT02768909Not applicable
- Evaluating Newly Approved Drugs for Multidrug-resistant TBCompletedNCT02754765Phase 3
- Structural and Functional Repercussions of Pulmonary Tuberculosis SequelaeCompletedNCT02736864
- Study of TB Lesions Obtained in Therapeutical SurgeryCompletedNCT02715271
- IGRA and Mantoux Response in Children With Suspected Latent or Active TB InfectionStatus unknownNCT02653404
- Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s)CompletedNCT02589782Phase 2/3
- A Randomised Trial to Evaluate Toxicity and Efficacy of 1200mg and 1800mg Rifampicin for Pulmonary TuberculosisCompletedNCT02581527Phase 3
- Intervention in the Management of Post-high Tuberculosis Hospital Through Educational Strategy and Oversight DistanceCompletedNCT02558842Not applicable
- 68Ga-AlfatideII for the Differential Diagnosis of of Lung Cancer and Lung Tuberculosis by PET/CTCompletedNCT02481726Phase 1/2
- Efficacy of HUEXC030 in Subjects With Pulmonary TuberculosisCompletedNCT02467608Phase 2/3
- Effect of Vitamin D as Adjunctive Therapy in Patients With Pulmonary Evolution TuberculosisStatus unknownNCT02464683Phase 4
- A Blinded, Cross-sectional, Diagnostic Evaluation Study Performed in Pulmonary TB Suspects at the TB Dispensary for Sector 4 of the Marius-Nasta-Institute in Bucharest, RomaniaCompletedNCT02382107
- Trial of Faropenem and Cefadroxil (in Combination With Amoxicillin/Clavulanic Acid and Standard TB Drugs) in Patients With Pulmonary Tuberculosis: Measurement of Early Bactericidal Activity and Effects on Novel BiomarkersCompletedNCT02381470Phase 2
- NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in TuberculosisCompletedNCT02371681Phase 2
- Phase 2 Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of Meropenem Plus Amoxycillin/CA and Faropenem Plus Amoxycillin/CA in Adult Patients With Newly Diagnosed Pulmonary TuberculosisCompletedNCT02349841Phase 2
- Research on New Regimens for Retreatment Pulmonary TuberculosisStatus unknownNCT02331823Phase 4
- Could the Stroke Volume Variation Predict a Fluid Responsiveness in Thoracotomy?CompletedNCT02331056
- Efficacy and Safety of Qinbudan as an Adjunct Therapy for Retreatment Pulmonary TuberculosisCompletedNCT02313610Phase 2
- A Phase 2 Trial to Evaluate the Efficacy and Safety of Linezolid in Tuberculosis Patients. (LIN-CL001)CompletedNCT02279875Phase 2
- ENOSE in Pulmonary Tuberculosis in YogyakartaCompletedNCT02219945Not applicable
- Effect of Supplementary Vitamin D in Patients With Diabetes Mellitus and Pulmonary TuberculosisStatus unknownNCT02169570Phase 4
- Pulmonary Tuberculosis Patients With Diabetes MellitusCompletedNCT02106039Not applicable
- Evaluation of PTB Screening in ANC in Lusaka, ZambiaCompletedNCT02053129Not applicable
- Linezolid Instead of Ethambutol in Treatment of Drug-susceptible TuberculosisStatus unknownNCT01994460Phase 2
- Interaction Between High Dose Rifampicine and Efavirenz in Pulmonary Tuberculosis and HIV Co-infectionStatus unknownNCT01986543Phase 2
- Cost-effectiveness of Two Forms of DOTS in a Demonstration Area of the DOTS Strategy in ColombiaCompletedNCT01945905Not applicable
- Phase 1 ID93 + GLA-SE Vaccine Trial in BCG-Vaccinated Healthy Adult VolunteersCompletedNCT01927159Phase 1
- Early Retinal Nerve Fiber Layer Change of Ethambutol Optic Neuropathy by Optical Coherence TomographyCompletedNCT01866579
- Immune Reconstitution in Tuberculosis DiseaseCompletedNCT01698476Phase 2
- Feasibility of a Lateral Flow Urine LAM Test for Diagnosis of Tuberculosis in South AfricaStatus unknownNCT01693224Not applicable
- The Role of Apoptosis Associated Markers in Pathogenesis of Pulmonary TuberculosisStatus unknownNCT01676155
- Safety and Efficacy of Blocking IL-4 With Pascolizumab in Patients Receiving Standard Therapy for Pulmonary TuberculosisStatus unknownNCT01638520Phase 2
- Phase 1 ID93 + GLA-SE Vaccine Trial in Healthy Adult VolunteersCompletedNCT01599897Phase 1
- Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis SuspectsCompletedNCT01587469
- Clinical Trial of Phenylbutyrate and Vitamin D in Tuberculosis (TB)CompletedNCT01580007Phase 2
- Feasibility of a Lateral Flow Urine Lipoarabinomannan (LAM) Test for Diagnosis of TuberculosisStatus unknownNCT01525134Not applicable
- Intensive Smoking-cessation Intervention Versus Smoking-cessation Advice in Smear-positive Patients With Pulmonary TuberculosisCompletedNCT01517022Phase 3
- Intestinal Tuberculosis Diagnostics and the Differentiation From Crohn's DiseaseStatus unknownNCT01503099
- Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary TuberculosisApproved for marketingNCT01464762
- Reintroduction Regimens After Hepatitis During Anti-tuberculosis TreatmentStatus unknownNCT01395654Phase 4
- Safety, Tolerability, Extended Early Bactericidal Activity and PK of Higher Doses Rifampicin in Adults With Pulmonary TBCompletedNCT01392911Phase 2
- Utility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in MaliTerminatedNCT01381757
- Tuberculosis Volatile Organic CompoundsCompletedNCT01379066
- Pharmacokinetics of Anti-tuberculosis Drugs in Gastrectomized PatientsCompletedNCT01364324
- Oral Urea Breath Testing for Diagnosis and Treatment Response in Pulmonary TuberculosisCompletedNCT01301144
- Homeopathy as an Adjuvant to Chemotherapy Improves Clinical Outcome in Relapsed Pulmonary TuberculosisCompletedNCT01242592Phase 2
- Early Bactericidal Activity (EBA) of SQ109 in Adult Subjects With Pulmonary TBCompletedNCT01218217Phase 2
- Latency in Pulmonary TuberculosisCompletedNCT01154959Phase 3
- Simple Verbal Intervention for Adequately Collecting SputumStatus unknownNCT01135043Phase 4